CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-16 | SCARLETT JOHN A Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-06-16 | Meyers James R Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-06-16 | Jones Elaine V Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-06-16 | GLUCK FREDERICK W Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-06-16 | Gilbert Halley E Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-06-14 | McCarthy Sean A. President and CEO | Option exercise | +30 | $1.13 | $34 | 7,839 |
| 2021-06-14 | McCarthy Sean A. President and CEO | Option exercise | +10 | $0.95 | $9 | 7,849 |
| 2021-06-14 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (Right to Buy) | −30 | 92,113 | ||
| 2021-06-14 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (Right to Buy) | −10 | 66,742 | ||
| 2021-05-31 | Campoy Carlos Chief Financial Officer | Grant or award | +3,320 | $6.09 | $20K | 6,421 |
| 2021-05-31 | Peterson Amy C. EVP, Chief Development Officer | Grant or award | +3,320 | $6.09 | $20K | 6,421 |
| 2021-03-31 | McCarthy Sean A. President and CEO | Option exercise | +100,000 | $1.13 | $113K | 306,894 |
| 2021-03-31 | McCarthy Sean A. President and CEO | Sale | −100,000 | $7.49 | $749K | 206,894 |
| 2021-03-31 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (Right to Buy) | −100,000 | 92,143 | ||
| 2021-02-27 | McCarthy Sean A. President and CEO | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2021-02-26 | Peterson Amy C. EVP, Chief Development Officer | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2021-02-26 | Campoy Carlos Chief Financial Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2021-02-26 | HANNAH ALISON L. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2021-02-26 | ROWLAND LLOYD A General Counsel | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2021-02-26 | McCarthy Sean A. President and CEO | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 |
Page 13 of 33 · 649 trades